Cargando…
[(99m)Tc]Tc-PentixaTec: development, extensive pre-clinical evaluation, and first human experience
PURPOSE: The clinical success non-invasive imaging of CXCR4 expression using [(68) Ga]Ga-PentixaFor-PET warrants an expansion of the targeting concept towards conventional scintigraphy/SPECT with their lower cost and general availability. To this aim, we developed and comparatively evaluated a serie...
Autores principales: | Konrad, Matthias, Rinscheid, Andreas, Wienand, Georgine, Nittbaur, Bernd, Wester, Hans-Jürgen, Janzen, Tilman, Lapa, Constantin, Pfob, Christian Helmut, Schottelius, Margret |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611619/ https://www.ncbi.nlm.nih.gov/pubmed/37597009 http://dx.doi.org/10.1007/s00259-023-06395-x |
Ejemplares similares
-
A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency
por: Osl, Theresa, et al.
Publicado: (2020) -
[(99cm)Tc]Tc-PSMA-I&S-SPECT/CT: experience in prostate cancer imaging in an outpatient center
por: Werner, P., et al.
Publicado: (2020) -
Comparison of [(99m)Tc]Tc-tilmanocept with [(99m)Tc]Tc-sulphur colloids and [(99m)Tc]Tc-albumin colloids for sentinel lymph node detection in patients with cutaneous malignancies of the head
por: Ooms, Mark, et al.
Publicado: (2022) -
Head to head comparison of [(99m)Tc]Tc(CO)(3)(NTA) and [(99m)Tc]Tc-MAG3 in patients with suspected obstruction
por: Taylor, Andrew T., et al.
Publicado: (2021) -
Optimization of the Pharmacokinetic Profile of [(99m)Tc]Tc-N(4)-Bombesin Derivatives by Modification of the Pharmacophoric Gln-Trp Sequence
por: Günther, Thomas, et al.
Publicado: (2022)